The 2019 AHS Annual Meeting is a 3 and a half day educational experience for health professionals interested in hernia repair.
Monday, March 11 - Thursday, March 14, 2019
Pre-Registration: Sunday, March 10 - 1:00-3:00pm
Registration: Monday, March 11 - 7:00am
ARIA Resort & Casino
3730 S Las Vegas Blvd
Las Vegas, NV 89158
Help promote AHS Annual Meeting 2019
Please use the AHS Annual Meeting promotional slide in all your upcoming presentations. The slide can be downloaded below:
2019 AHS Annual Meeting will emphasize state of the art management of abdominal wall disorders based on current clinical experience, clinical evidence and ongoing clinical and basic science research. Renown clinical experts and researchers in private and university practices from around the world will present technique, evidence and controversies followed by a forum of open discussion for various approaches to the management of common, unique and complex hernias. Newer techniques and ongoing research will be highlighted during free paper, poster of distinction, poster and video sessions. History, socioeconomics, politics, medicolegal issues and the future of hernia repair will be discussed.
This activity has been designed to meet the educational needs of general surgeons, plastic surgeons, trauma surgeons and any other medical professional interested in hernia.
After completing this activity, the participant should be better able to:
-Describe the indications and contraindications for laparoscopic ventral hernia repair
-Recognize the role of robotics in ventral hernia repair
-Discuss the efforts of the Americas Hernia Society Quality Collaborative
-Identify common advantages and disadvantages for various prosthetic materials in ventral hernia repairs
Accreditation and Credit Statements
In support of improving patient care, this activity has been planned and implemented by the Medical Educator Consortium and the Americas Hernia Society. In support of improving patient care, the Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Medical Educator Consortium designates this live activity for a maximum of 25.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical Educator Consortium (MEC) adheres to the Joint Accreditation Criteria and ACCME Standards for Commercial Support, which requires everyone in a position of controlling the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests related to the activity content. MEC has implemented a mechanism to identify and resolve all conflicts of interest prior to the CME/CE activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity. CME/CE activities must be balanced, independent of commercial bias, and designed to improve quality in health care. All recommendations involving clinical medicine must be based on evidence within the medical profession.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contradictions, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contradictions and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.